New depression drug shows promise in early trial
Symptom relief
Recruiting now
This study tests a new drug called GM-2505 for people with major depressive disorder. It involves two doses given two weeks apart. The goal is to see if the drug is safe and helps reduce depression symptoms. The study includes 124 adults aged 18 to 65 who are either not on antide…
Phase: PHASE2 • Sponsor: Gilgamesh Pharmaceuticals • Aim: Symptom relief
Last updated May 05, 2026 11:56 UTC